110 related articles for article (PubMed ID: 7767260)
1. Prognostic factors in Hodgkin's disease: problems and pitfalls.
Phillips G
Leuk Lymphoma; 1995; 15 Suppl 1():43-5. PubMed ID: 7767260
[No Abstract] [Full Text] [Related]
2. Prognostic factors in advanced Hodgkin's disease: problems and pitfalls. Towards an international prognostic index.
Gisselbrecht C; Ferme C
Leuk Lymphoma; 1995; 15 Suppl 1():23-4. PubMed ID: 7767254
[No Abstract] [Full Text] [Related]
3. Hodgkin's and non-Hodgkin's lymphomas.
McElwain TJ
Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
[No Abstract] [Full Text] [Related]
4. Treatment of Hodgkin's disease: should the punishment fit the crime?
Gulati SC; Gelfand R; Coleman M; Wolf D
Leuk Lymphoma; 1995; 15 Suppl 1():27-9. PubMed ID: 7767256
[No Abstract] [Full Text] [Related]
5. [Recent progress in the treatment of hematological malignancies. V. Recent results of chemotherapy and major prognostic factors in patients with T-cell lymphoma, B-cell lymphoma and Hodgkin's disease].
Ohta K; Shimoyama M
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):802-8. PubMed ID: 2794662
[No Abstract] [Full Text] [Related]
6. High-risk Hodgkin's disease prognostic factors.
Straus DJ
Leuk Lymphoma; 1995; 15 Suppl 1():41-2. PubMed ID: 7767259
[No Abstract] [Full Text] [Related]
7. [New prognostic factors in the treatment of patients with stage-III Hodgkin's disease].
Girshovich MM; Kanaev SV; Pozharisskiĭ KM; Golovanov SG; Barbashov AI
Vopr Onkol; 2010; 56(4):424-9. PubMed ID: 20968021
[TBL] [Abstract][Full Text] [Related]
8. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
[TBL] [Abstract][Full Text] [Related]
9. [Results of treatment of Hodgkin's disease; 15 years' experience of the Nijmegen and Utrecht University Hospitals].
van Rijswijk RE; Verbeek J; Haanen C; Dekker AW; van Daal WA; van Peperzeel HA
Ned Tijdschr Geneeskd; 1987 Oct; 131(42):1866-70. PubMed ID: 3118223
[No Abstract] [Full Text] [Related]
10. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
Ali A; Sayed H; Farrag A; El-Sayed M
Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
[TBL] [Abstract][Full Text] [Related]
12. [Hodgkin's disease; a regional retrospective study].
Erdkamp FL; Wijlhuizen TJ; van Dam FE
Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1801-6. PubMed ID: 3141820
[No Abstract] [Full Text] [Related]
13. [Therapeutic strategies of Hodgkin's disease].
Lathan B; Pfreundschuh M; Diehl V
Internist (Berl); 1993 Feb; 34(2):146-54. PubMed ID: 8454428
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of patients with Hodgkin's disease treated at the Institute of Hematology 1974-1983].
Kopeć I; Leszko B; Słomkowski M; Pawelski S; Maj S
Acta Haematol Pol; 1988; 19(3-4):126-36. PubMed ID: 3252661
[No Abstract] [Full Text] [Related]
15. [Hodgkin's disease--a curable disease].
Kotlarek-Haus S; Gabryś K; Sciborski R; Gałazka Z; Jeleń M; Fischer W
Pol Tyg Lek; 1988 Aug; 43(33):1047-52. PubMed ID: 3244571
[No Abstract] [Full Text] [Related]
16. International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
Moccia AA; Donaldson J; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Shenkier TN; Slack GW; Skinnider B; Gascoyne RD; Connors JM; Sehn LH
J Clin Oncol; 2012 Sep; 30(27):3383-8. PubMed ID: 22869887
[TBL] [Abstract][Full Text] [Related]
17. Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's disease.
Voillat L; Deconinck E; Flesch M; Brion A; Rozenbaum A; Vuillier J; Pavy JJ; Angonin R; Carbillet JP; Hervé P
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):423-30. PubMed ID: 7753613
[TBL] [Abstract][Full Text] [Related]
18. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
19. State-of-the-art therapeutics: Hodgkin's lymphoma.
Connors JM
J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
[TBL] [Abstract][Full Text] [Related]
20. [A suggested program of combined treatment of Hodgkin's disease in children].
Balwierz W; Armata J; Moryl-Bujakowska A; Strzeszyński J; Depowska T
Pol Tyg Lek; 1988 Dec; 43(50):1637-40. PubMed ID: 2476790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
